Exact Sciences Corporation EXAS was a big mover last session, as the company saw its shares rise nearly 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $46.49 to $51.16 in the past one-month time frame.
The move came after the company reported better-than-expected third-quarter 2017 results.
The company has seen one positive estimate revision in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Exact Sciences. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Exact Sciences currently has a Zacks Rank #2 (Buy) while its Earnings ESP is positive%.
Exact Sciences Corporation Price
Exact Sciences Corporation Price | Exact Sciences Corporation Quote
Investors interested in the Medical – Biomedical and Genetics industry may consider Axovant Sciences Ltd. AXON, which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is EXAS going up? Or down? Predict to see what others think:Up or Down
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment